Retaane anecortave acetate: Preliminary Phase III data

One-year data from a Phase III trial comparing Retaane to

Read the full 105 word article

User Sign In

Article Purchase

This article may not be distributed to non-subscribers

PURCHASE THIS ARTICLE FOR LIMITED ONE-TIME DISTRIBUTION AND WEBSITE POSTING $995.00 USD

PURCHASE